Cislini Jeff's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 19, 2026
- Accession no.
- 0001610717-26-000127
- Filed
- Mar 19, 2026
- Trade date
- Mar 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $291.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cislini JeffCIK 0001969082 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock | SSaleDisposed | −1,795 | $99.48 | −$178,566.6 | 59,681 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −1,163 | $97.44 | −$113,322.72 | 58,518 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.